RSV-specific humoral and cellular immune responses in kidney transplant recipients
Transplant International · 30.10.2026 · 39
DOI: 10.3389/ti.2026.17558 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transplant International, online erschienen am 30.10.2026. Verfasst von Britte G Lenderink und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Erasmus MC Transplant Institute, Erasmus Medical Center, Rotterdam, Netherlands. Hauptthemen laut MEDLINE: Kidney Transplantation, Immunity, Cellular, Immunity, Humoral, Respiratory Syncytial Virus Infections. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Induction of virus-specific immune responses in kidney transplant recipients (KTR) by vaccination is challenging. However, it is not well-described whether pre-existing immunity against respiratory viruses initially encountered before transplantation, like respiratory syncytial virus (RSV), is maintained. Therefore, we assessed RSV-specific humoral and cellular immune responses in KTR and controls at two timepoints during the COVID-19 pandemic. Binding and neutralizing antibodies were determined in serum samples from 64 KTR and 37 controls. Cellular immune responses were measured in a cohort subset (15 KTR, 14 controls) by stimulation of peripheral blood mononuclear cells with RSV-derived peptide pools. This was followed by phenotypic analysis using an activation-induced marker assay and cytokine release assay. RSV-specific binding IgG and neutralizing antibody titers were comparable between KTR and controls and stable over time. While total lymphocyte levels were significantly lower in KTR, relative frequencies of RSV-specific CD4 + and CD8 + memory T cells were comparable between groups. Unsupervised hierarchical clustering distinguished three cytokine production profiles with divergent RSV-specific immune responses, but KTR and controls were equally distributed throughout. Thus, KTR have comparable RSV-specific humoral and cellular immune responses to controls. Our findings suggest that pre-existing respiratory virus-specific immune responses persist under immunosuppressive treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Erasmus MC Transplant Institute, Erasmus Medical Center, Rotterdam, Netherlands.
- Department of Viroscience, Erasmus Medical Center, Rotterdam, Netherlands.
Zitieren
APA
Lenderink, B. G., van Dijk, L. L. A., Dieterich, M., Kho, M. M. L., Heidt, S., & de Vries, R. D. (2026). RSV-specific humoral and cellular immune responses in kidney transplant recipients. Transplant International, 39. https://doi.org/10.3389/ti.2026.17558
Vancouver
Lenderink BG, van Dijk LLA, Dieterich M, Kho MML, Heidt S, de Vries RD. RSV-specific humoral and cellular immune responses in kidney transplant recipients. Transplant International. 2026;39. doi:10.3389/ti.2026.17558
BibTeX
@article{Lenderink2026,
author = {Lenderink, Britte G and van Dijk, Laura L A and Dieterich, Marjolein and Kho, Marcia M L and Heidt, Sebastiaan and de Vries, Rory D},
title = {RSV-specific humoral and cellular immune responses in kidney transplant recipients},
journal = {Transplant International},
year = {2026},
volume = {39},
doi = {10.3389/ti.2026.17558}
}
EUVIMED